NASDAQ:ONEM - 1Life Healthcare Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $38.63
  • Forecasted Upside: 75.57 %
  • Number of Analysts: 16
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 13 Buy Ratings
  • 0 Strong Buy Ratings
$22.00
▲ +0.71 (3.33%)

This chart shows the closing price for ONEM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New 1Life Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ONEM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ONEM

Analyst Price Target is $38.63
▲ +75.57% Upside Potential
This price target is based on 16 analysts offering 12 month price targets for 1Life Healthcare in the last 3 months. The average price target is $38.63, with a high forecast of $63.00 and a low forecast of $22.00. The average price target represents a 75.57% upside from the last price of $22.00.

This chart shows the closing price for ONEM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 16 contributing investment analysts is to buy stock in 1Life Healthcare.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/28/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 0 sell ratings
7/27/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/25/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/23/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/23/2021
  • 0 strong buy ratings
  • 11 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/22/2021
  • 0 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings
9/20/2021
  • 0 strong buy ratings
  • 13 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/20/2021

Latest Recommendations

  • 0 strong buy ratings
  • 13 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/13/2021Truist SecuritiesLower Price TargetBuy$48.00 ➝ $28.00Low
10/13/2021TruistLower Price TargetBuy$48.00 ➝ $28.00Low
10/7/2021CitigroupLower Price TargetBuy$46.00 ➝ $32.00High
9/27/2021SVB LeerinkInitiated CoverageMarket Perform$22.00High
9/24/2021Piper SandlerLower Price TargetOverweight$55.50 ➝ $37.00High
8/12/2021BarclaysInitiated CoverageOverweight$32.00Low
8/9/2021Robert W. BairdDowngradeOutperform ➝ Neutral$43.00 ➝ $31.00High
8/5/2021Canaccord GenuityLower Price TargetBuy$48.00 ➝ $40.00Low
8/5/2021KeyCorpLower Price TargetOverweight$41.00 ➝ $38.00High
8/5/2021Deutsche Bank AktiengesellschaftLower Price TargetNeutral ➝ Buy$39.00 ➝ $34.00High
8/5/2021CitigroupBoost Price TargetBuy$46.00 ➝ $55.00High
6/29/2021Canaccord GenuityLower Price TargetBuy$56.00 ➝ $48.00Medium
6/9/2021Deutsche Bank AktiengesellschaftLower Price TargetBuy$50.00 ➝ $39.00Medium
5/27/2021Robert W. BairdInitiated CoverageOutperform$43.00High
5/21/2021KeyCorpInitiated CoverageOverweight$41.00Medium
5/17/2021Credit Suisse GroupLower Price TargetOutperform$56.00 ➝ $50.00Low
5/13/2021TruistLower Price TargetBuy ➝ Buy$56.00 ➝ $48.00Low
5/13/2021CitigroupLower Price TargetBuy ➝ Buy$61.00 ➝ $55.00High
5/13/2021Canaccord GenuityLower Price TargetBuy$64.00 ➝ $56.00High
5/3/2021Jefferies Financial GroupInitiated CoverageBuy$63.00Medium
3/15/2021Evercore ISIInitiated CoverageOutperform$48.00Medium
3/1/2021Credit Suisse GroupBoost Price TargetOutperform$40.00 ➝ $56.00N/A
3/1/2021Morgan StanleyBoost Price TargetOverweight$44.00 ➝ $50.00N/A
2/26/2021TruistBoost Price Target$40.00 ➝ $56.00Low
2/26/2021SVB LeerinkLower Price TargetOutperform$55.00 ➝ $53.00Medium
2/26/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$42.00 ➝ $53.00Medium
2/4/2021CitigroupBoost Price Target$42.00 ➝ $62.00Low
1/29/2021SVB LeerinkUpgradeMarket Perform ➝ Outperform$38.00 ➝ $55.00Low
1/8/2021Piper SandlerBoost Price TargetOverweight$44.00 ➝ $51.00Low
1/7/2021Canaccord GenuityBoost Price TargetFocus Stock ➝ Buy$46.00 ➝ $50.00Low
1/6/2021BTIG ResearchInitiated CoverageNeutralN/A
12/16/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$38.00 ➝ $42.00High
12/16/2020Canaccord GenuityBoost Price TargetBuy$41.00 ➝ $46.00High
11/11/2020Smith Barney CitigroupBoost Price Target$38.00 ➝ $42.00Low
11/11/2020Canaccord GenuityBoost Price TargetBuy$39.00 ➝ $41.00Low
11/11/2020JPMorgan Chase & Co.Reiterated RatingOverweight$40.00 ➝ $43.00High
11/11/2020Credit Suisse GroupBoost Price TargetOutperform$37.00 ➝ $40.00High
11/11/2020Piper SandlerBoost Price TargetOverweight$43.00 ➝ $44.00Medium
11/11/2020SVB LeerinkBoost Price TargetMarket Perform$36.00 ➝ $38.00High
11/11/2020Morgan StanleyBoost Price TargetOverweight$35.00 ➝ $41.00High
10/30/2020Credit Suisse GroupInitiated CoverageOutperform$37.00High
10/14/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$37.00High
8/14/2020TruistBoost Price Target$30.00 ➝ $36.00Medium
8/13/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$23.00 ➝ $28.00Medium
7/17/2020Piper SandlerBoost Price TargetOverweight$40.00 ➝ $43.00Medium
7/8/2020CitigroupBoost Price TargetPositive ➝ Neutral$20.00 ➝ $38.00Low
7/1/2020SVB LeerinkInitiated CoverageMarket Perform$36.00Medium
6/30/2020Piper SandlerBoost Price TargetOverweight$29.00 ➝ $40.00High
6/19/2020Canaccord GenuityInitiated CoverageBuy$39.00High
5/18/2020Morgan StanleyBoost Price TargetOverweight$21.00 ➝ $35.00Medium
5/14/2020SunTrust BanksBoost Price TargetBuy$26.00 ➝ $30.00Medium
5/14/2020Piper SandlerReiterated RatingOverweight$27.00 ➝ $29.00High
5/14/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$18.00 ➝ $23.00High
4/1/2020CitigroupLower Price TargetNeutral$25.00 ➝ $20.00High
3/19/2020Morgan StanleyLower Price TargetOverweight$27.00 ➝ $21.00High
2/25/2020Morgan StanleyInitiated CoverageOverweight$27.00High
2/25/2020Wells Fargo & CompanyInitiated CoverageEqual Weight$24.00High
2/25/2020Robert W. BairdInitiated CoverageNeutral$24.00High
2/25/2020JPMorgan Chase & Co.Initiated CoverageOverweight$28.00High
2/25/2020SunTrust BanksInitiated CoverageBuy$30.00High
2/25/2020CitigroupInitiated CoverageNeutral$25.00High
2/25/2020William BlairInitiated CoverageOutperformHigh
2/25/2020Piper SandlerInitiated CoverageOverweight$29.00High
(Data available from 10/20/2016 forward)

News Sentiment Rating

0.21 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/24/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/23/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/23/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/22/2021
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/22/2021
  • 2 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/21/2021
  • 4 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/20/2021
  • 4 very positive mentions
  • 9 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
10/20/2021

Current Sentiment

  • 4 very positive mentions
  • 9 positive mentions
  • 5 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
1Life Healthcare logo
1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as employer sponsorship. Its membership model includes seamless access to digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2020, it had approximately 549,000 members in 13 markets in the United States; and 8,000 enterprise clients. The company was incorporated in 2002 and is headquartered in San Francisco, California.
Read More

Today's Range

Now: $22.00
Low: $21.30
High: $22.07

50 Day Range

MA: $22.83
Low: $19.51
High: $25.26

52 Week Range

Now: $22.00
Low: $19.10
High: $59.82

Volume

2,018,731 shs

Average Volume

1,419,894 shs

Market Capitalization

$3.03 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.27

Frequently Asked Questions

What sell-side analysts currently cover shares of 1Life Healthcare?

The following Wall Street sell-side analysts have issued research reports on 1Life Healthcare in the last year: Barclays PLC, BTIG Research, Canaccord Genuity, Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Evercore ISI, Jefferies Financial Group Inc., JPMorgan Chase & Co., KeyCorp, Morgan Stanley, Piper Sandler, Robert W. Baird, Smith Barney Citigroup, SVB Leerink LLC, Truist, Truist Securities, and Zacks Investment Research.
View the latest analyst ratings for ONEM.

What is the current price target for 1Life Healthcare?

16 Wall Street analysts have set twelve-month price targets for 1Life Healthcare in the last year. Their average twelve-month price target is $38.63, suggesting a possible upside of 81.4%. Jefferies Financial Group Inc. has the highest price target set, predicting ONEM will reach $63.00 in the next twelve months. SVB Leerink LLC has the lowest price target set, forecasting a price of $22.00 for 1Life Healthcare in the next year.
View the latest price targets for ONEM.

What is the current consensus analyst rating for 1Life Healthcare?

1Life Healthcare currently has 3 hold ratings and 13 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ONEM will outperform the market and that investors should add to their positions of 1Life Healthcare.
View the latest ratings for ONEM.

What other companies compete with 1Life Healthcare?

How do I contact 1Life Healthcare's investor relations team?

1Life Healthcare's physical mailing address is One Embarcadero Center Suite 1900, San Francisco CA, 94111. The official website for 1Life Healthcare is www.onemedical.com.